TACO1 and neoplasm: Consistent with our in vitro findings, data from subcutaneous tumor formation and orthotopic BCa models demonstrated that TACO1 knockdown inhibited the tumor‐initiating capacity and cisplatin resistance of T24‐CIS cells in vivo (Figure 3D–F).